Keeping Up with the Times, Striving Forward — The Inauguration Ceremony of Discovery Pharma and the Successful Hosting of the \"Prospects and Opportunities for Pharmaceutical Professionals in the New Era\" Salon!

Reading frequency:687  Updated on:2023-05-16

Since its establishment in 2018, Chiheal Group has adhered to the principles of being clinically demand-driven, innovation-focused, and customer-centered. Through high-quality, efficient, and cost-effective research and development services, the company has helped clients seize timely opportunities related to consistency evaluation, MAH new policies, and centralized procurement. This has empowered the development and growth of partner enterprises, enabling all parties to achieve rapid and high-quality development.

Discovery Pharma is an independent pharmaceutical research and development platform under Chiheal Group, with several divisions including the Chemical Innovative Drug Research Institute, Chemical Generic Drug Research Institute, and Traditional Chinese Medicine Research Institute. The company boasts a complete quality management system, internationally advanced formulation equipment and analytical instruments, as well as an experienced management and research team. Currently, it is capable of undertaking small molecule drug research projects, generic drug development and consistency evaluation, research and development of traditional Chinese medicine and natural drugs, pharmaceutical regulatory registration consulting, and MAH collaborative R&D projects. It provides a strong source of innovative development power for a wide range of pharmaceutical innovation projects.

The Traditional Chinese Medicine Research Institute established by Discovery Pharma is equipped with a professional technical team and a group of renowned domestic experts. The institute is dedicated to the research and development of innovative Chinese medicine and technical services. It offers one-stop services including the development of Chinese medicine varieties (innovative Chinese medicines, improved drugs, classic formulas, same name and same formula, in-hospital formulations, completion of unclear content in product instructions, and changes and supplementary applications for product varieties), registration consulting and filing, as well as the transformation and promotion of research results.

On May 12, 2023, the inauguration ceremony of Discovery Pharma was successfully held at Guoxiaotang A5 Building. Nearly 100 leaders from domestic pharmaceutical industry associations, representatives from over 50 pharmaceutical companies nationwide, renowned industry experts, venture capital leaders, and university professors gathered at the event to exchange ideas and provide guidance. The ceremony focused on the cutting-edge developments of the industry, with a grand celebration marking the establishment of our company.

The Inauguration Ceremony was hosted by Zhang Haibo, General Manager of Chiheal Aikang Pharma.

First, Dr. Zhang Zhefeng, Chairman of Chiheal Group, delivered the opening speech, warmly welcoming and sincerely thanking the guests for their presence at the ceremony.

Professor Wang Shujun, Chairwoman of the China Pharmaceutical Education Association, and Mr. Zhang Yuxiang, Vice President of the China Chemical Pharmaceutical Association and Chairman of the Hebei Province Biomanufacturing Industry Alliance, both delivered speeches, expressing their high expectations for the development of Discovery Pharmaceutical.

Mr. Mathias Glintborg, Chief Representative of International Cooperation at Chiheal Group, extended his heartfelt congratulations on the opening of Discovery Pharmaceutical.

Professor Wang Lianshui, Executive Vice Chairman of the Hebei Pharmaceutical Society, extended his warm congratulations on the inauguration of Discovery Pharmaceutical.

Finally, Ms. Hou Wen, General Manager of Discovery Pharma once again expressed her gratitude to all the guests for their presence and shared her confidence in the future development of Discovery Pharmaceutical. With the support and assistance of various associations and alliances, Discovery will strive forward, continuously innovate its service models, and work to become an outstanding representative of domestic R&D.

PREV: Talking About the Power of Capital, Achieving Mutual Empowerment with the Greater Health Industry — Chiheal Listed on the Most Investment-Worthy Pharmaceutical Companies List
NEXT: Joyful News | Nanjing Chiheal Bio-Tech is Awarded the Title of National Specialized, Refined, Characteristic, and Innovative (Little giants)Enterprise!